Understanding B-cell tolerance through the use of immunoglobulin transgenic models

Kirthi Raman Kumar, Chandra Mohan

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The appearance of autoantibodies in autoimmune diseases such as lupus suggests that B-cell tolerance to self is breached. Hence it becomes important to unravel the precise cellular and molecular mechanisms that are responsible for violations in various B-cell tolerance checkpoints in autoimmune diseases. B-cell immunoglobulin or B-cell receptor transgenic models have been of immense aid in uncovering many of these key tolerance checkpoints during normal B-cell development. By breeding these transgenic models onto mice that are engineered to lack or hyperexpress various B-cell molecules, including signaling intermediates, researchers have delineated the role of these molecules in B-cell tolerance. These transgenic models have also been useful in delineating the impact of various lupus prone genomes and lupus susceptibility loci on B-cell tolerance. This review focuses on some of the more well-studied B-cell receptor transgenic models and the lessons they have taught us over the past two decades.

Original languageEnglish (US)
Pages (from-to)208-223
Number of pages16
JournalImmunologic Research
Volume40
Issue number3
DOIs
StatePublished - Mar 2008

Fingerprint

Immunoglobulins
B-Lymphocytes
Autoimmune Diseases
Autoantibodies
Breeding
Research Personnel
Genome

Keywords

  • Anergy
  • Autoimmunity
  • BCR
  • Deletion
  • Immunoglobulin
  • Lupus
  • Receptor editing
  • Tolerance
  • Transgenic

ASJC Scopus subject areas

  • Immunology

Cite this

Understanding B-cell tolerance through the use of immunoglobulin transgenic models. / Kumar, Kirthi Raman; Mohan, Chandra.

In: Immunologic Research, Vol. 40, No. 3, 03.2008, p. 208-223.

Research output: Contribution to journalArticle

@article{b07926608f434828a46dc17d6e17befa,
title = "Understanding B-cell tolerance through the use of immunoglobulin transgenic models",
abstract = "The appearance of autoantibodies in autoimmune diseases such as lupus suggests that B-cell tolerance to self is breached. Hence it becomes important to unravel the precise cellular and molecular mechanisms that are responsible for violations in various B-cell tolerance checkpoints in autoimmune diseases. B-cell immunoglobulin or B-cell receptor transgenic models have been of immense aid in uncovering many of these key tolerance checkpoints during normal B-cell development. By breeding these transgenic models onto mice that are engineered to lack or hyperexpress various B-cell molecules, including signaling intermediates, researchers have delineated the role of these molecules in B-cell tolerance. These transgenic models have also been useful in delineating the impact of various lupus prone genomes and lupus susceptibility loci on B-cell tolerance. This review focuses on some of the more well-studied B-cell receptor transgenic models and the lessons they have taught us over the past two decades.",
keywords = "Anergy, Autoimmunity, BCR, Deletion, Immunoglobulin, Lupus, Receptor editing, Tolerance, Transgenic",
author = "Kumar, {Kirthi Raman} and Chandra Mohan",
year = "2008",
month = "3",
doi = "10.1007/s12026-007-8008-7",
language = "English (US)",
volume = "40",
pages = "208--223",
journal = "Immunologic Research",
issn = "0257-277X",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Understanding B-cell tolerance through the use of immunoglobulin transgenic models

AU - Kumar, Kirthi Raman

AU - Mohan, Chandra

PY - 2008/3

Y1 - 2008/3

N2 - The appearance of autoantibodies in autoimmune diseases such as lupus suggests that B-cell tolerance to self is breached. Hence it becomes important to unravel the precise cellular and molecular mechanisms that are responsible for violations in various B-cell tolerance checkpoints in autoimmune diseases. B-cell immunoglobulin or B-cell receptor transgenic models have been of immense aid in uncovering many of these key tolerance checkpoints during normal B-cell development. By breeding these transgenic models onto mice that are engineered to lack or hyperexpress various B-cell molecules, including signaling intermediates, researchers have delineated the role of these molecules in B-cell tolerance. These transgenic models have also been useful in delineating the impact of various lupus prone genomes and lupus susceptibility loci on B-cell tolerance. This review focuses on some of the more well-studied B-cell receptor transgenic models and the lessons they have taught us over the past two decades.

AB - The appearance of autoantibodies in autoimmune diseases such as lupus suggests that B-cell tolerance to self is breached. Hence it becomes important to unravel the precise cellular and molecular mechanisms that are responsible for violations in various B-cell tolerance checkpoints in autoimmune diseases. B-cell immunoglobulin or B-cell receptor transgenic models have been of immense aid in uncovering many of these key tolerance checkpoints during normal B-cell development. By breeding these transgenic models onto mice that are engineered to lack or hyperexpress various B-cell molecules, including signaling intermediates, researchers have delineated the role of these molecules in B-cell tolerance. These transgenic models have also been useful in delineating the impact of various lupus prone genomes and lupus susceptibility loci on B-cell tolerance. This review focuses on some of the more well-studied B-cell receptor transgenic models and the lessons they have taught us over the past two decades.

KW - Anergy

KW - Autoimmunity

KW - BCR

KW - Deletion

KW - Immunoglobulin

KW - Lupus

KW - Receptor editing

KW - Tolerance

KW - Transgenic

UR - http://www.scopus.com/inward/record.url?scp=46149085377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46149085377&partnerID=8YFLogxK

U2 - 10.1007/s12026-007-8008-7

DO - 10.1007/s12026-007-8008-7

M3 - Article

C2 - 17943232

AN - SCOPUS:46149085377

VL - 40

SP - 208

EP - 223

JO - Immunologic Research

JF - Immunologic Research

SN - 0257-277X

IS - 3

ER -